3D Systems Corporation (NYSE:DDD), Kate Spade & Co (NYSE:KATE), Clorox Co (NYSE:CL) Watch Before the Market Opens Tomorrow
DDD: Commercial 3D printers appear to be a thing of the past, but that doesn’t mean the technology is dead. 3D systems key profit drivers have come from its healthcare offerings. During the first quarter revenue from healthcare related products increased 12% year over year, driven by higher demand for printable medical devices. The ability to print precision tools on the fly is proving to be lucrative for 3D systems. Apart from healthcare the company is focused on expanding quickparts services, accelerating 3D printer adoption, and strengthening partnerships. Shares are up 45% this year as these new initiatives have started to pay off.
KATE: Luxury retail has been one of the more beaten down sectors in recent years as consumers opt for thrifty options. Kate Spade, however, has largely bucked the trend registering strong same store sales and impressive comparables. Kate Spade’s string of success has come on the back of an expanding ecommerce platform and international growth. Last quarter saw a 19% increase in DTC comparable sales and 3.2% jump in international sales. Continued efforts to expand along with strong brand recognition will be key to driving growth moving forward.
CLX: Consumer staples have been resilient though this year and Clorox is no different. Clorox has been gaining from a series of cost cutting and efficiency initiatives. The company has also a broader long term strategy that will continue to take effect through 2020. Many of its core brands such as Brita and Burt’s Bees have already started to grow. Clorox also regained distribution of its products at Costco after conceding the business to Reckitt Benckiser nearly two years ago. A recent acquisition of Renew Life provide Clorox with access to the health and wellness market. Renew Life’s products can be found at stores such as Whole Foods, Sprouts and Vitamin Shoppe. Investor’s probably don’t mind that Clorox isn’t the most glamorous company given the way it has performed.
How do you think these names will report? Be included in the Estimize consensus by contributing your estimates here!
